Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

PROSHARES TRUST (ZBIO) Return on Equity: 2024-2025

Historic Return on Equity for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to -0.89%.

  • Zenas BioPharma's Return on Equity rose 277.00% to -0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.89%, marking a year-over-year increase of 277.00%. This contributed to the annual value of -3.72% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Zenas BioPharma's Return on Equity stood at -0.89%, which was down 28.72% from -0.69% recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Return on Equity peaked at 0.20% during Q2 2024, and registered a low of -3.66% during Q3 2024.
  • For the 2-year period, Zenas BioPharma's Return on Equity averaged around -1.01%, with its median value being -0.62% (2025).
  • Over the last 5 years, Zenas BioPharma's Return on Equity had its largest YoY gain of 277bps in 2025, and its largest YoY loss of 89bps in 2025.
  • Quarterly analysis of 2 years shows Zenas BioPharma's Return on Equity stood at -0.48% in 2024, then surged by 277bps to -0.89% in 2025.
  • Its last three reported values are -0.89% in Q3 2025, -0.69% for Q2 2025, and -0.56% during Q1 2025.